Correlation Between Cyclacel Pharmaceuticals and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Tempest Therapeutics, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Tempest Therapeutics.
Diversification Opportunities for Cyclacel Pharmaceuticals and Tempest Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cyclacel and Tempest is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Cyclacel Pharmaceuticals and Tempest Therapeutics
Given the investment horizon of 90 days Cyclacel Pharmaceuticals is expected to under-perform the Tempest Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cyclacel Pharmaceuticals is 5.92 times less risky than Tempest Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Tempest Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 146.00 in Tempest Therapeutics on September 4, 2024 and sell it today you would lose (51.00) from holding Tempest Therapeutics or give up 34.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Cyclacel Pharmaceuticals vs. Tempest Therapeutics
Performance |
| Timeline |
| Cyclacel Pharmaceuticals |
| Tempest Therapeutics |
Cyclacel Pharmaceuticals and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclacel Pharmaceuticals and Tempest Therapeutics
The main advantage of trading using opposite Cyclacel Pharmaceuticals and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
| Tempest Therapeutics vs. Candel Therapeutics | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. Unicycive Therapeutics | Tempest Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |